Northwestern Medicine investigators have discovered previously unknown metabolic changes that may contribute to the ...

Current models of resistance discovered in genomic studies of breast cancer tumors which are understudy include: Rho GDIa, the androgen receptor (AR), Dicer1, breast cancer resistance protein (BCRP1), ...

The counteraction of estrogens and progesterone in SHBG results in the enhancement of this binding protein ... counters estrogen effect by blocking the aldosterone receptor, thus being ...

Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...